A well-established and state-of-the-art technology platform is of fundamental importance for a robust, safe, and cost-efficient biopharmaceutical production process. The eukaryotic and prokaryotic expression systems of EUGENEX’s proprietary technology platform meet these requirements and are perfect vehicles for bringing a product to success. While our technology platform is approved by many regulatory authorities worldwide, the systems are constantly being optimized to further increase product quality and quantity.
Check out our innovative eukaryotic and procaryotic expression systems.